Abstract:Actin cytoskeleton is well-known for providing structural/mechanical support, but whether and how it regulates chromatin and cell fate reprogramming is far less clear. Here, we report that MKL1, the key transcriptional co-activator of many actin cytoskeletal genes, regulates genomic accessibility and cell fate reprogramming. The MKL1-actin pathway weakens during somatic cell reprogramming by pluripotency transcription factors. Cells that reprogram efficiently display low endogenous MKL1 and inhibition of actin… Show more
“…Indeed, when we FACS sorted cells based on forward scatter alone, a crude measure of cell size, and compared their reprogramming efficiency, smaller cells indeed displayed higher reprogramming activity (Figures 4B-C). Such observation is consistent with our previous finding that reprogramming requires reduced MKL1/SRF activity (Hu et al, 2019).…”
Section: Caglow Cells Are Small In Size With Reduced Srf Target Genessupporting
confidence: 94%
“…We examined whether CAG:H2B-GFP intensity decreases during early reprogramming to reflect the decreasing MKL1/SRF activity (Hu et al, 2019). Shortly after Dox addition, there was a marked down-regulation of CAG:H2B-GFP intensity within the mCherry+ population ( Figures 1B-C), consistent with reduced activity of MKL1/SRF.…”
Section: Cells Expressing Low Cag Promoter Activity Emerge During Earmentioning
confidence: 99%
“…These transcription factors are now known to antagonize Yamanka reprogramming, or established pluripotency by redefining the enhancer-Pol II relationship (Chronis et al, 2017;Hamilton et al, 2019;Liu et al, 2015). We have recently reported that MKL1/SRF activity potently prevents the activation of mature pluripotency by hindering chromatin accessibility via an actin-LINC-dependent process (Hu et al, 2019). Taken together, these evidences suggest that the transcriptional activity of the ubiquitously expressed SRF could potentially serve as an indicator for how likely a somatic cell could progress into pluripotency.…”
There is wide variability in the propensity of somatic cells to reprogram into pluripotency in response to the Yamanaka factors. How to segregate these variability to enrich for cells of specific traits that reprogram efficiently remains challenging. Here we report that the variability in reprogramming propensity is associated with the activity of the MKL1/SRF transcription factor and concurs with small cell size as well as rapid cell cycle. Reprogramming progressive cells can be prospectively identified by their low activity of a widely used synthetic promoter, CAG. CAGlow cells arise and expand during cell cycle acceleration in the early reprogramming culture of both mouse and human fibroblasts. Our work illustrate a molecular scenario underlying the distinct reprogramming propensities and demonstrate a convenient practical approach for their enrichment.
“…Indeed, when we FACS sorted cells based on forward scatter alone, a crude measure of cell size, and compared their reprogramming efficiency, smaller cells indeed displayed higher reprogramming activity (Figures 4B-C). Such observation is consistent with our previous finding that reprogramming requires reduced MKL1/SRF activity (Hu et al, 2019).…”
Section: Caglow Cells Are Small In Size With Reduced Srf Target Genessupporting
confidence: 94%
“…We examined whether CAG:H2B-GFP intensity decreases during early reprogramming to reflect the decreasing MKL1/SRF activity (Hu et al, 2019). Shortly after Dox addition, there was a marked down-regulation of CAG:H2B-GFP intensity within the mCherry+ population ( Figures 1B-C), consistent with reduced activity of MKL1/SRF.…”
Section: Cells Expressing Low Cag Promoter Activity Emerge During Earmentioning
confidence: 99%
“…These transcription factors are now known to antagonize Yamanka reprogramming, or established pluripotency by redefining the enhancer-Pol II relationship (Chronis et al, 2017;Hamilton et al, 2019;Liu et al, 2015). We have recently reported that MKL1/SRF activity potently prevents the activation of mature pluripotency by hindering chromatin accessibility via an actin-LINC-dependent process (Hu et al, 2019). Taken together, these evidences suggest that the transcriptional activity of the ubiquitously expressed SRF could potentially serve as an indicator for how likely a somatic cell could progress into pluripotency.…”
There is wide variability in the propensity of somatic cells to reprogram into pluripotency in response to the Yamanaka factors. How to segregate these variability to enrich for cells of specific traits that reprogram efficiently remains challenging. Here we report that the variability in reprogramming propensity is associated with the activity of the MKL1/SRF transcription factor and concurs with small cell size as well as rapid cell cycle. Reprogramming progressive cells can be prospectively identified by their low activity of a widely used synthetic promoter, CAG. CAGlow cells arise and expand during cell cycle acceleration in the early reprogramming culture of both mouse and human fibroblasts. Our work illustrate a molecular scenario underlying the distinct reprogramming propensities and demonstrate a convenient practical approach for their enrichment.
“…demonstrated that low actin cytoskeleton is critical for the maturation of reprogramming fibroblasts. Elevated actin cytoskeleton by sustained MKL1 activity potently restricts nuclear dynamics, reduces chromatin accessibility, and inhibits pluripotency activation, partly through constricting the nuclei via the linker of nucleoskeleton and cytoskeleton complex . This work depicts a novel perspective on how cell cycle could regulate cell fate and demonstrates how a ubiquitous structural network could regulate nuclear dynamics and control cell fate.…”
Section: Potential Molecular Consequences Of Rapid Cell Cyclementioning
confidence: 85%
“…In the fibroblast reprogramming model, dramatic downregulation of the actin cytoskeleton occurs as cells undergo this fate transition [100,101]. The systematic reduction of the actin cytoskeletal network is caused by reduced activity of the transcription factors megakaryoblastic leukemia-1/serum response factor (MKL1/SRF) [101]. Hu et al demonstrated that low actin cytoskeleton is critical for the maturation of reprogramming fibroblasts.…”
Section: Heightened Chromatin Accessibility From a Weakened Actin Cytmentioning
Reprogramming of cellular identity is fundamentally at odds with replication of the genome: cell fate reprogramming requires complex multidimensional epigenomic changes, whereas genome replication demands fidelity. In this review, we discuss how the pace of the genome's replication and cell cycle influences the way daughter cells take on their identity. We highlight several biochemical processes that are pertinent to cell fate control, whose propagation into the daughter cells should be governed by more complex mechanisms than simple templated replication. With this mindset, we summarize multiple scenarios where rapid cell cycle could interfere with cell fate copying and promote cell fate reprogramming. Prominent examples of cell fate regulation by specific cell cycle phases are also discussed. Overall, there is much to be learned regarding the relationship between cell fate reprogramming and cell cycle control. Harnessing cell cycle dynamics could greatly facilitate the derivation of desired cell types.
There is wide variability in the propensity of somatic cells to reprogram into pluripotency in response to the Yamanaka factors. How to segregate these variabilities to enrich for cells of specific traits that reprogram efficiently remains challenging. Here we report that the variability in reprogramming propensity is associated with the activity of the MKL1/SRF transcription factor and concurs with small cell size as well as rapid cell cycle. Reprogramming progressive cells can be prospectively identified by their low activity of a widely used synthetic promoter, CAG. CAGlow cells arise and expand during cell cycle acceleration in the early reprogramming culture of both mouse and human fibroblasts. Our work illustrates a molecular scenario underlying the distinct reprogramming propensities and demonstrates a convenient practical approach for their enrichment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.